US weighs up India patent response

A spokeswoman for the US Trade Representative’s office said yesterday it was considering its response to an Indian Supreme Court ruling that US drug manufacturers warn is the latest sign of a deteriorating environment for intellectual property rights in the country. India’s top court on Monday dismissed Swiss drugmaker Novartis’s attempt to win patent protection for its cancer drug Glivec.